by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Auriga Research Pvt. Ltd. Warning Letter Details

Warning Letter

Auriga Research Pvt. Ltd.

Recipient Title Managing Director and CEO, 3/17 Kirti Nagar, Industrial Area New Delhi 110015 India, (b)(4)

Issue DateAugust 12, 2026

FEI Number3019975128

Violations3

CountryIndia

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Auriga Research Pvt. Ltd. FDA Warning Letter, August 12, 2026